Monitoring of plasma concentrations of dabrafenib and trametinib in advanced BRAFV600mut melanoma patients

Autor: Raynal, M., Alvarez, J.-C., Saiag, P., Beauchet, A., Funck-Brentano, C., Funck-Brentano, E.

Publikováno v: In Annales de Dermatologie et de Vénéréologie March 2022 149(1):32-38

Clinical pharmacology of anti-angiogenic drugs in oncology

Autor: Gougis, P., Wassermann, J., Spano, J.P., Keynan, N., Funck-Brentano, C., Salem, J.E.

Publikováno v: In Critical Reviews in Oncology / Hematology November 2017 119:75-93

Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytes

Autor: Salem, J.E., Yang, T., Moslehi, J.J., Waintraub, X., Gandjbakhch, E., Bachelot, A., Hidden-Lucet, F., Hulot, J.S., Knollmann, B.C., Lebrun-Vignes, B., Funck-Brentano, C., Glazer, A.M., Roden, D.M.

Publikováno v: In Annales d'Endocrinologie June 2021 82(3-4):132-133

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

Autor: Knuuti, Juhani, Wijns, William, Saraste, Antti, Capodanno, Davide, Barbato, Emanuele, Funck-Brentano, Christian, Prescott, Eva, Storey, Robert F, Deaton, Christi, Cuisset, Thomas, Agewall, Stefan, Dickstein, Kenneth, Edvardsen, Thor, Escaned, Javier, Gersh, Bernard J, Svitil, Pavel, Gilard, Martine, Hasdai, David, Hatala, Robert, Mahfoud, Felix, Masip, Josep, Muneretto, Claudio, Valgimigli, Marco, Achenbach, Stephan, Bax, Jeroen J, Neumann FJ, Sechtem U, Banning AP, Bonaros N, Bueno H, Bugiardini R, Chieffo A, Crea F, Czerny M, Delgado V, Dendale P, Flachskampf FA, Gohlke H, Grove EL, James S, Katritsis D, Landmesser U, Lettino M, Matter CM, Nathoe H, Niessner A, Patrono C, Petronio AS, Pettersen SE, Piccolo R, Piepoli MF, Popescu BA, Räber L, Richter DJ, Roffi M, Roithinger FX, Shlyakhto E, Sibbing D, Silber S, Simpson IA, Sousa-Uva M, Vardas P, Witkowski A, Zamorano JL, Achenbach S, Agewall S, Barbato E, Bax JJ, Capodanno D, Cuisset T, Deaton C, Dickstein K, Edvardsen T, Escaned J, Funck-Brentano C, Gersh BJ, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Prescott E, Saraste A, Storey RF, Svitil P, Valgimigli M, Windecker S, Aboyans V, Baigent C, Collet JP, Dean V, Fitzsimons D, Gale CP, Grobbee D, Halvorsen S, Hindricks G, Iung B, Jüni P, Katus HA, Leclercq C, Lewis BS, Merkely B, Mueller C, Petersen S, Touyz RM, Benkhedda S, Metzler B, Sujayeva V, Cosyns B, Kusljugic Z, Velchev V, Panayi G, Kala P, Haahr-Pedersen SA, Kabil H, Ainla T, Kaukonen T, Cayla G, Pagava Z, Woehrle J, Kanakakis J, Tóth K, Gudnason T, Peace A, Aronson D, Riccio C, Elezi S, Mirrakhimov E, Hansone S, Sarkis A, Babarskiene R, Beissel J, Maempel AJC, Revenco V, de Grooth GJ, Pejkov H, Juliebø V, Lipiec P, Santos J, Chioncel O, Duplyakov D, Bertelli L, Dikic AD, Studenčan M, Bunc M, Alfonso F, Bäck M, Zellweger M, Addad F, Yildirir A, Sirenko Y, Clapp B

Publikováno v: European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2019, 41 (3), pp.407-477. ⟨10.1093/eurheartj/ehz425⟩
Knuuti, Juhani; Wijns, William; Saraste, Antti; Capodanno, Davide; Barbato, Emanuele; Funck-Brentano, Christian; Prescott, Eva; Storey, Robert F; Deaton, Christi; Cuisset, Thomas; Agewall, Stefan; Dickstein, Kenneth; Edvardsen, Thor; Escaned, Javier; Gersh, Bernard J; Svitil, Pavel; Gilard, Martine; Hasdai, David; Hatala, Robert; Mahfoud, Felix; ... (2020). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European heart journal, 41(3), pp. 407-477. Oxford University Press 10.1093/eurheartj/ehz425
Knuuti, J, Wijns, W, Saraste, A, Capodanno, D, Barbato, E, Funck-Brentano, C, Prescott, E, Storey, R F, Deaton, C, Cuisset, T, Agewall, S, Dickstein, K, Edvardsen, T, Escaned, J, Gersh, B J, Svitil, P, Gilard, M, Hasdai, D, Hatala, R, Mahfoud, F, Masip, J, Muneretto, C, Valgimigli, M, Achenbach, S, Bax, J J & ESC Scientific Document Group 2020, ' 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes ', European Heart Journal, vol. 41, no. 3, pp. 407-477 . https://doi.org/10.1093/eurheartj/ehz425
European heart journal, 41(3), 407. Oxford University Press
European Heart Journal, 2019, 41 (3), pp.407-477. ⟨10.1093/eurheartj/ehz425⟩

Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4841cc616e782106cf775dfa6d8ec813
https://hal.sorbonne-universite.fr/hal-02374039

Tolérance cardiaque de la moxifloxacine : expérience clinique issue d'une large étude observationnelle française en pratique médicale usuelle (étude IMMEDIAT)

Autor: Veyssier, P., Voirot, P., Begaud, B., Funck-Brentano, C.

Publikováno v: In Médecine et Maladies Infectieuses 2006 36(10):505-512